A similar increase in ER-α-positive proliferating cells has previously been reported in more advanced precursors (e.g. ADH and DCIS) and invasive breast cancer [35,38,39], which is consistent with the hypothesis that HELUs represent an earlier stage of the same continuum. Here, ESR1 is linked to ductal breast carcinoma in situ.